
Protagenix Therapeutics is currently trading as an over-the-counter stock. But the company plans to launche on the New York Stock Exchange (NYSE) soon, which will make it easier for everyday investors to buy in.
How to buy Protagenic Therapeutics stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – PTIX. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Protagenic Therapeutics stock price (NASDAQ: PTIX)
Use our graph to track the performance of PTIX stocks over time.Protagenic Therapeutics shares at a glance
Latest market close | $0.59 |
---|---|
52-week range | $0.33 - $1.23 |
50-day moving average | $0.49 |
200-day moving average | $0.65 |
Wall St. target price | $4.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.29 |
Buy Protagenic Therapeutics stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Protagenic Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Protagenic Therapeutics price performance over time
Historical closes compared with the close of $0.59 from 2023-01-27
1 week (2023-01-23) | 5.36% |
---|---|
1 month (2022-12-30) | 47.50% |
3 months (2022-10-28) | 0.59 |
6 months (2022-07-29) | 0.59 |
1 year (2022-01-28) | -46.36% |
---|---|
2 years (2021-01-28) | -85.78% |
3 years (2020-01-30) | 1.4101 |
5 years (2018-01-26) | N/A |
Protagenic Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -23.63% |
Return on equity TTM | -43.31% |
Profit margin | 0% |
Book value | $0.43 |
Market capitalisation | $9.7 million |
TTM: trailing 12 months
Protagenic Therapeutics share dividends
We're not expecting Protagenic Therapeutics to pay a dividend over the next 12 months.
Have Protagenic Therapeutics's shares ever split?
Protagenic Therapeutics's shares were split on a 1:15464 basis on 27 July 2016. So if you had owned 15464 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Protagenic Therapeutics shares – just the quantity. However, indirectly, the new 1546300% higher share price could have impacted the market appetite for Protagenic Therapeutics shares which in turn could have impacted Protagenic Therapeutics's share price.
Protagenic Therapeutics share price volatility
Over the last 12 months, Protagenic Therapeutics's shares have ranged in value from as little as $0.33 up to $1.23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Protagenic Therapeutics's is 0.0572. This would suggest that Protagenic Therapeutics's shares are less volatile than average (for this exchange).
To put Protagenic Therapeutics's beta into context you can compare it against those of similar companies.
Protagenic Therapeutics overview
Protagenic Therapeutics, Inc. , a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York. .
Frequently asked questions
What percentage of Protagenic Therapeutics is owned by insiders or institutions?Currently 21.197% of Protagenic Therapeutics shares are held by insiders and 9.014% by institutions. When does the fiscal year end for Protagenic Therapeutics?
Protagenic Therapeutics's fiscal year ends in December. Where is Protagenic Therapeutics based?
Protagenic Therapeutics's address is: 149 Fifth Avenue, New York, NY, United States, 10010 What is Protagenic Therapeutics's ISIN number?
Protagenic Therapeutics's international securities identification number is: US74365N1037 What is Protagenic Therapeutics's CUSIP number?
Protagenic Therapeutics's Committee on Uniform Securities Identification Procedures number is: 71376K102
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert